rs776276760
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1
The NM_005732.4(RAD50):c.1245+2C>G variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000747 in 1,606,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005732.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Nijmegen breakage syndrome-like disorderInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RAD50 | NM_005732.4 | c.1245+2C>G | splice_donor_variant, intron_variant | Intron 8 of 24 | ENST00000378823.8 | NP_005723.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RAD50 | ENST00000378823.8 | c.1245+2C>G | splice_donor_variant, intron_variant | Intron 8 of 24 | 1 | NM_005732.4 | ENSP00000368100.4 | |||
| ENSG00000283782 | ENST00000638452.2 | c.948+2C>G | splice_donor_variant, intron_variant | Intron 10 of 26 | 5 | ENSP00000492349.2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152070Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000201 AC: 5AN: 249340 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000756 AC: 11AN: 1454566Hom.: 0 Cov.: 31 AF XY: 0.00000829 AC XY: 6AN XY: 723954 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74414 show subpopulations
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
This sequence change falls in intron 8 of the RAD50 gene. It does not directly change the encoded amino acid sequence of the RAD50 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs776276760, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with RAD50-related conditions. ClinVar contains an entry for this variant (Variation ID: 240209). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). RNA analysis performed to evaluate the impact of this variant on mRNA splicing indicates it does not significantly alter splicing (Invitae). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
The c.1245+2C>G intronic variant results from a C to G substitution two nucleotides after coding exon 8 in the RAD50 gene. This nucleotide position is conserved through primates but not in all available vertebrate species. The BDGP and ESEfinder splice site prediction tools do not produce a reliable prediction for the nearby native splice donor site. The HSF splice site prediction tool does not predict any significant impact on the native splice donor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at